Moderna Aktie

Moderna für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2N9D9 / ISIN: US60770K1079

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
08.03.2021 15:20:57

Baxter BioPharma Reaches Deal For Fill/Finish Manufacturing Of Moderna COVID-19 Vaccine In U.S.

(RTTNews) - Baxter International Inc. (BAX) and Moderna Inc. ( MRNA) said that they have reached an agreement by which Baxter BioPharma Solutions to provide fill/finish sterile manufacturing services and supply packaging for about 60-90 million doses of the Moderna COVID-19 Vaccine in 2021. Additional details of the agreement were not disclosed.

Baxter's BioPharma Solutions business is a premier contract manufacturing organization that specializes in parenteral (injectable) pharmaceuticals, including vaccines.

The manufacturing of the Moderna COVID-19 vaccine will take place at the BioPharma Solutions fill/finish sterile manufacturing facilities located in Bloomington, Indiana.

Analysen zu Moderna Incmehr Analysen

19.11.24 Moderna Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
13.09.24 Moderna Underweight JP Morgan Chase & Co.
05.08.24 Moderna Sector Perform RBC Capital Markets
12.01.24 Moderna Outperform RBC Capital Markets
03.11.23 Moderna Buy Goldman Sachs Group Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Baxter International Inc. 27,06 -1,17% Baxter International Inc.
Moderna Inc 24,32 -2,72% Moderna Inc